Conviction portfolio: 12 rounds in AI and data
Rounds where Conviction led or took part, newest first. Led: 1.
- Harvey raises $550M, . AI apps. Led by Diffusion, Lightspeed Venture Partners. Builds generative AI tools for law firms and in-house legal teams.
- Onyx Security raises $113M Series B, . Security. Led by Bessemer Venture Partners. Onyx Security monitors enterprise AI agents and enforces governance rules on their actions in real time.
- Onyx Security raises $40M Series A, . Security. Led by Conviction, Cyberstarts. Onyx Security provides a control plane to observe, secure and govern enterprise AI agents and models.
- Harvey raises $160M, . AI apps. Led by Andreessen Horowitz. Builds generative AI tools for law firms and in-house legal teams.
- Baseten raises $150M Series D, . AI infrastructure. Led by BOND. Baseten provides infrastructure for deploying and serving AI models in production with fast, reliable inference.
- OpenEvidence raises $210M Series B, . AI apps. Led by GV, Kleiner Perkins. OpenEvidence offers an AI medical search and clinical decision support tool for doctors.
- Harvey raises $300M Series E, . AI apps. Led by Kleiner Perkins, Coatue. Builds generative AI tools for law firms and in-house legal teams.
- Cognition raises an undisclosed round, . Developer tools. Led by 8VC. Builds Devin, an autonomous AI software engineer, and owns the Windsurf editor.
- Baseten raises $75M Series C, . AI infrastructure. Led by IVP, Spark Capital. Baseten provides infrastructure for deploying and serving AI models in production with fast, reliable inference.
- Harvey raises $300M Series D, . AI apps. Led by Sequoia Capital. Builds generative AI tools for law firms and in-house legal teams.
- Cartesia raises $27M Seed, . AI models. Led by Index Ventures. Cartesia builds real-time voice AI models, including low-latency text to speech, based on state space model research.
- Chai Discovery raises $30M Seed, . AI models. Led by Thrive Capital, OpenAI, Dimension. Chai Discovery builds AI foundation models for predicting and designing molecules such as antibodies for drug discovery.